People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study. (Source: ScienceDaily Headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: Bisphosphonates, Cancer, double, esophageal, finds, long, Oral, risk, Study, term
Conclusions S-1 plus docetaxel combination therapy in an outpatient setting provided promising activity with acceptable adverse toxicities.
Content Type Journal ArticleDOI 10.1007/s00280-010-1433-7Authors
Chikara Kunisaki, Department of Surgery, Gastroenterological Center, Yokohama City University, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024 JapanMasazumi Takahashi, Department of Surgery, Yokohama Municipal Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, 240-0062 JapanHirochika Makino, Department of Surgery, Gastroenterological Center, Yokohama City University, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024 JapanTakashi Oshima, Department of Surgery, Gastroenterological Center, Yokohama City University, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024 JapanShoichi …
Source: MedWorm: Oral Cancer
Tags: Advanced, Biweekly, Cancer, chemotherapy., Combination, docetaxel, FirstLine, Gastric, Phase, Study, Treatment
Conclusions Overall, we found little indication that reproductive factors or use of exogenous sex hormones affect meningioma risk.
Content Type Journal ArticleDOI 10.1007/s10552-010-9634-2Authors
K. Korhonen, Unit of Neurosurgery, Turku University Hospital, PL 52, 20521 Turku, FinlandJ. Raitanen, School of Public Health, University of Tampere, Tampere, FinlandJ. Isola, Laboratory of Cancer Biology, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, FinlandH. Haapasalo, Department of Pathology, Tampere University Hospital, Tampere, FinlandT. Salminen, School of Public Health, University of Tampere, Tampere, FinlandA. Auvinen, School of Public Health, University of Tampere, Tampere, Finland
Journal Cancer Causes and Con… Source: MedWorm: Oral Cancer
Tags: caseâcontrol, Exogenous, Finland, Hormone., meningioma, populationbased, risk, Study
Conclusion
Pyridoxine is not effective in prevention of capecitabine-associated HFS. (Source: Journal of Clinical Oncology)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: associated, Capecitabine, Complications, doubleblind, Effective, HandFoot, placebocontrolled, Prevent, Pyridoxine, randomized, Results, Study, syndrome, therapy, TreatmentRelated
Conclusion The SOx regimen evidenced a relatively high response rate and was well tolerated as a first-line therapy for advanced gastric
cancer.
Content Type Journal ArticleDOI 10.1007/s10637-010-9507-2Authors
Sung Yong Oh, Department of Internal Medicine, Dong-A University College of Medicine, Busan, KoreaHyuk-Chan Kwon, Department of Internal Medicine, Dong-A University College of Medicine, Busan, KoreaSang-Ho Jeong, Departments of Surgery, Gyeongsang National University Hospital, Jinju, South KoreaYoung-Tae Joo, Departments of Surgery, Gyeongsang National University Hospital, Jinju, South KoreaYoung-Joon Lee, Departments of Surgery, Gyeongsang National University Hospital, Jinju, South KoreaSu hee Cho, Departments of Internal Medicine, Gyeongsang National University Hospital, Ji…
Source: MedWorm: Oral Cancer
Tags: Advanced, Cancer, chemotherapy., Combination, FirstLine, Gastric, oxaliplatin, patients, Phase, Study, therapy
A large cohort study examines the possible link between the use of oral bisphosphonates and esophageal and gastric cancers. Medscape Medical News (Source: Medscape Today Headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: Bisphosphonates, Cancer, esophageal, linked, says, Study
Researchers have reported that African-American women who use oral contraceptives have a greater likelihood of developing breast cancer than nonusers. The study results were based on data from the Black Women’s Health Study, a large follow-up study of 59,000 African-American women from across the US conducted by investigators at the Slone Epidemiology Center since 1995. (Source: ScienceDaily Headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: AfricanAmerican, associated, Breast, Cancer, Contraceptive, finds, increased, Oral, risk, Study, Women
(Source: Monsters and Critics Health News)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: betel, blames, Cancer, cent, finds, Oral, Rates, Study, Taiwan
Conclusion
Combination chemotherapy with bevacizumab and erlotinib showed clinical activity with infrequent grade 3 and 4 adverse effects in patients with advanced biliary cancers. On the basis of preliminary molecular analysis, presence of a k-ras mutation may alter erlotinib efficacy. The combination of bevacizumab and erlotinib may be a therapeutic alternative in patients with advanced biliary cancer. (Source: Journal of Clinical Oncology)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Source: MedWorm: Oral Cancer
Tags: Bevacizumab, Biliary, Biweekly, Cancer, Combination, consortium, Daily, Erlotinib, Gastrointestinal, Multicenter, patients, Phase, Report, Study, Testing, Trial, Unresectable
(International & American Association for Dental Research) Today during the 88th General Session & Exhibition of the International Association for Dental Research, in Barcelona, Spain, presenting author J. Meyle, Justus Liebig University, Giessen, Germany, will present an abstract titled “P.gingivalis Infection and Immune Evasion of Oral Carcinomas.” (Source: EurekAlert! – Medicine and Health) Source: MedWorm: Oral Cancer
Tags: cancers, disease, Oral, periodontal, relationship, researchers, Study